The Board of Directors of Dong-A PharmTech Co. Ltd. (KOSE:A140410) authorized a share repurchase program on April 27, 2012. Under the program, the company will repurchase up to 350,877 shares for KRW 5 bllion based on the closing price of company's share on April 26, 2012. Repurchases will be made from the stock exchange market. The purpose behind the program is to stabilize the stock price. The company will repurchase up to 35,087 shares on any one day in the program. Repurchases will commence on April 30, 2012 and will continue until July 30, 2012. As of April 26, 2012, the company has 271,567 shares in treasury under trust agreement. KB Investment & Securities Co., Ltd. acted as the broker to the company for the buyback.